Standard BioTools (LAB) came out with a quarterly loss of $0.04 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.08 per share a year ago. These figures are adjusted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results